Acute amiodarone promotes drift and early termination of spiral wave re-entry

Heart Vessels. 2010 Jul;25(4):338-47. doi: 10.1007/s00380-009-1184-8. Epub 2010 Jul 31.

Abstract

Intravenous application of amiodarone is commonly used in the treatment of life-threatening arrhythmias, but the underlying mechanism is not fully understood. The purpose of the present study is to investigate the acute effects of amiodarone on spiral wave (SW) re-entry, the primary organization machinery of ventricular tachycardia/fibrillation (VT/VF), in comparison with lidocaine. A two-dimensional ventricular myocardial layer was obtained from 24 Langendorff-perfused rabbit hearts, and epicardial excitations were analyzed by high-resolution optical mapping. During basic stimulation, amiodarone (5 microM) caused prolongation of action potential duration (APD) by 5.6%-9.1%, whereas lidocaine (15 microM) caused APD shortening by 5.0%-6.4%. Amiodarone and lidocaine reduced conduction velocity similarly. Ventricular tachycardias induced by DC stimulation in the presence of amiodarone were of shorter duration (sustained-VTs >30 s/total VTs: 2/58, amiodarone vs 13/52, control), whereas those with lidocaine were of longer duration (22/73, lidocaine vs 14/58, control). Amiodarone caused prolongation of VT cycle length and destabilization of SW re-entry, which is characterized by marked prolongation of functional block lines, frequent wavefront-tail interactions near the rotation center, and considerable drift, leading to its early annihilation via collision with anatomical boundaries. Spiral wave re-entry in the presence of lidocaine was more stabilized than in control. In the anisotropic ventricular myocardium, amiodarone destabilizes SW re-entry facilitating its early termination. Lidocaine, in contrast, stabilizes SW re-entry resulting in its persistence.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Amiodarone / pharmacology*
  • Animals
  • Anti-Arrhythmia Agents / pharmacology*
  • Cardiac Pacing, Artificial
  • Disease Models, Animal
  • Electrophysiologic Techniques, Cardiac
  • Heart Conduction System / drug effects*
  • Heart Conduction System / physiopathology
  • Heart Ventricles / drug effects
  • Heart Ventricles / physiopathology
  • Kinetics
  • Lidocaine / pharmacology*
  • Perfusion
  • Rabbits
  • Tachycardia, Ventricular / drug therapy*
  • Tachycardia, Ventricular / physiopathology

Substances

  • Anti-Arrhythmia Agents
  • Lidocaine
  • Amiodarone